a 2545 has been researched along with lidocaine in 1 studies
| Studies (a 2545) | Trials (a 2545) | Recent Studies (post-2010) (a 2545) | Studies (lidocaine) | Trials (lidocaine) | Recent Studies (post-2010) (lidocaine) |
|---|---|---|---|---|---|
| 9 | 1 | 0 | 26,090 | 5,904 | 5,591 |
| Protein | Taxonomy | a 2545 (IC50) | lidocaine (IC50) |
|---|---|---|---|
| Sodium channel protein type 4 subunit alpha | Homo sapiens (human) | 2 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bódi, I; Frank, L; Hankovszky, OH; Hideg, K | 1 |
1 other study(ies) available for a 2545 and lidocaine
| Article | Year |
|---|---|
New antiarrhythmic agents. 2,2,5,5-Tetramethyl-3-pyrroline-3-carboxamides and 2,2,5,5-tetramethylpyrrolidine-3-carboxamindes.
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Drug Evaluation, Preclinical; Indicators and Reagents; Magnetic Resonance Spectroscopy; Nicotine; Ouabain; Rats; Spectrophotometry, Infrared; Structure-Activity Relationship | 1986 |